Veli-Matti Leppänen Selected Research

Veli-Matti Leppänen Research Topics

6	Neoplasms (Cancer) 01/2019 - 12/2010
3	Lymphedema (Milroy Disease) 01/2022 - 01/2020
3	Edema (Dropsy) 01/2020 - 08/2013
3	Inflammation (Inflammations) 04/2016 - 01/2013
2	Adenoma (Adenomas) 01/2021 - 10/2018
1	Hyperplasia 01/2020
1	Breast Neoplasms (Breast Cancer) 07/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 10/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2017
1	Body Weight (Weight, Body) 04/2016
1	Obesity 04/2016
1	Weight Loss (Weight Reduction) 04/2016
1	Glaucoma 09/2014
1	Cardiomegaly (Heart Hypertrophy) 07/2014
1	Heart Failure 07/2014
1	Neoplasm Metastasis (Metastasis) 08/2013
1	Pathologic Processes 08/2013
1	Hemangioma (Angioma) 01/2013
1	Pathologic Neovascularization 02/2010
1	Parkinson Disease (Parkinson's Disease) 07/2007

6	Vascular Endothelial Growth Factor CIBA 01/2022 - 02/2010
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 12/2010
3	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 09/2014 - 02/2010
2	TIE Receptors (TIE Receptor Tyrosine Kinases)IBA 01/2022 - 10/2017
2	AngiopoietinsIBA 01/2022 - 10/2017
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2020
2	Vascular Endothelial Growth Factor BIBA 04/2016 - 07/2014
2	Vascular Endothelial Growth FactorsIBA 08/2013 - 12/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	IntegrinsIBA 01/2020
1	taxaneIBA 07/2019
1	Bevacizumab (Avastin)FDA Link 07/2019
1	Angiogenesis InhibitorsIBA 01/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2019
1	Mi-2 Nucleosome Remodeling and Deacetylase ComplexIBA 10/2018
1	CateninsIBA 10/2018
1	Transcription Factors (Transcription Factor)IBA 10/2018
1	LipidsIBA 04/2016
1	Insulin (Novolin)FDA Link 04/2016
1	Placenta Growth FactorIBA 08/2013
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2013
1	LigandsIBA 12/2010
1	Blocking AntibodiesIBA 12/2010
1	AntibodiesIBA 12/2010
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2010
1	Oxidopamine (6 Hydroxydopamine)IBA 07/2007

1	Combination Drug Therapy (Combination Chemotherapy) 07/2019
1	Therapeutics 12/2010